What are the causes of muscle rigidity in a moribund patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Muscle Rigidity in a Moribund Patient

In a moribund patient, muscle rigidity most commonly results from neuroleptic malignant syndrome (NMS), malignant hyperthermia, tetanus, severe sepsis with metabolic derangements, or drug-induced hypermetabolic states—all life-threatening conditions requiring immediate recognition and intervention.

Life-Threatening Drug-Induced Causes

Neuroleptic Malignant Syndrome (NMS)

  • NMS presents as a tetrad of mental status changes, fever, hypertonicity/rigidity, and autonomic dysfunction due to dopamine D2 receptor blockade in the CNS 1
  • The pathophysiology involves D2 receptor antagonism in nigrostriatal pathways and spinal cord producing muscle rigidity, while peripheral calcium release from sarcoplasmic reticulum causes increased contractility, heat production, and muscle breakdown 1
  • Mortality has decreased from 76% in the 1960s to <10-15% currently, but remains lethal without prompt recognition 1
  • Risk factors include coadministration of multiple psychotropic agents (>50% of cases), dehydration, physical exhaustion, and preexisting organic brain disease 1
  • Consider NMS in any moribund patient with fever and altered mental status who is taking or may have taken an antipsychotic medication 1

Malignant Hyperthermia

  • Characterized by fulminant hypermetabolism of skeletal muscle with skeletal muscle rigidity, tachycardia, tachypnea, hypercarbia, metabolic acidosis, and fever 2
  • Triggered by inhalation anesthetics or depolarizing muscle relaxants in susceptible individuals 2, 3
  • Dantrolene sodium is the specific treatment and should be administered by continuous rapid IV push as soon as recognized 2
  • The hypermetabolic reaction leads to rapidly evolving rigidity, extensive rhabdomyolysis, and hyperkalemia 3

Serotonin Syndrome

  • Results from excessive serotonergic activity, presenting with hyperthermia, muscle rigidity, and altered mental status 3
  • Frequently accompanied by intense skeletal muscle hypermetabolic reaction leading to rhabdomyolysis and hyperkalemia 3

Infectious Causes

Tetanus

  • Produces severe muscle rigidity and spasms due to tetanospasmin blocking inhibitory neurotransmitters 1, 3
  • Hypoxemia and metabolic acidosis are common at admission and predict mortality 4
  • Mortality is significantly higher in patients with admission PaO2 <70 mmHg (p<0.01) or pH <7.2 (p<0.05) 4
  • Muscle relaxants may be needed to control severe muscle spasms, though succinylcholine should be avoided in immobilized patients 1

CNS Infections

  • Encephalitis and meningitis can present with rigidity, altered mental status, and fever 3
  • Must be differentiated from drug-induced causes through CSF analysis and imaging 3

Metabolic and Systemic Causes

Severe Sepsis with Metabolic Derangements

  • Muscle relaxants should NOT be used in sepsis except for endotracheal intubation and mechanically ventilated patients with severe respiratory distress 1
  • Metabolic acidosis from tissue hypoperfusion can contribute to muscle dysfunction 1
  • Prolonged immobilization (≥3 days) creates risk for hyperkalemia if depolarizing muscle relaxants are used 1

Rhabdomyolysis and Myonecrosis

  • Excessive calcium accumulation in skeletal muscle causes myocyte death and severe muscle rigidity 1
  • Can result from drug-induced hypermetabolic states, prolonged immobilization, or severe metabolic derangements 1
  • Monitor creatine kinase and potassium closely to prevent myoglobinuric renal failure and dysrhythmias 1

Neurological Causes in Moribund Patients

Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM)

  • Rare subacute disorder characterized by muscle rigidity, stimulus-sensitive spasms, and brainstem dysfunction with poor prognosis 1
  • Associated with glycine receptor antibodies (GlyR-Abs) in some cases 1
  • Pathological findings include perivascular lymphocyte cuffing and neuronal loss in brainstem and spinal cord 1

Parkinsonism (Less Likely in Acute Moribund State)

  • Rigidity presents as constant resistance to passive movement throughout entire range of motion 5, 6
  • Typically develops gradually after 40-50% of dopaminergic neurons are lost, not acutely in moribund patients 5
  • Lead-pipe rigidity shows smooth constant resistance; cogwheel rigidity has ratchet-like quality when combined with tremor 5

Critical Diagnostic Algorithm

Step 1: Medication History

  • Identify any antipsychotic use (typical or atypical), recent anesthesia exposure, or serotonergic agents 1, 3
  • Check for recent changes in psychotropic medications or dopamine agonist withdrawal 1

Step 2: Vital Signs and Associated Features

  • Fever + rigidity + altered mental status + autonomic instability = NMS until proven otherwise 1
  • Tachycardia, tachypnea, hypercarbia, and metabolic acidosis suggest malignant hyperthermia 2
  • Stimulus-sensitive spasms with preserved consciousness suggest tetanus 4, 3

Step 3: Laboratory Evaluation

  • Creatine kinase (markedly elevated in NMS, malignant hyperthermia, rhabdomyolysis) 1, 3
  • Arterial blood gas (hypoxemia and acidosis predict mortality in tetanus) 4
  • Electrolytes, particularly potassium (hyperkalemia from muscle breakdown) 1, 3
  • Blood cultures and inflammatory markers if sepsis suspected 1

Step 4: Immediate Management Priorities

  • Discontinue all potential causative agents immediately 1, 3
  • Aggressive temperature reduction for drug-induced hyperthermia 3
  • Dantrolene sodium for confirmed or suspected malignant hyperthermia 2
  • Supportive care in intensive care setting with close monitoring 1, 3

Critical Pitfalls to Avoid

  • Do NOT use succinylcholine in patients immobilized ≥3 days or with neuromuscular diseases due to risk of treatment-resistant hyperkalemia 1
  • Do NOT use muscle relaxants in septic patients except for intubation or severe respiratory distress 1
  • Do NOT delay treatment while awaiting confirmatory tests in suspected NMS or malignant hyperthermia—these are clinical diagnoses requiring immediate intervention 1, 2, 3
  • Do NOT confuse parkinsonian rigidity (chronic, progressive) with acute rigidity in moribund patients 5, 6
  • Do NOT assume rigidity is solely neurological—always consider metabolic, infectious, and drug-induced causes first in acute presentations 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-induced hyperthermia and muscle rigidity: a practical approach.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2003

Research

Alteration in blood gases in tetanus.

The Journal of the Association of Physicians of India.., 1994

Guideline

Parkinson's Disease Rigidity Pathophysiology and Clinical Manifestations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.